Back to Search Start Over

Coumarin-poly(2-oxazoline)s as synergetic and protein-undetected nanovectors for photodynamic therapy.

Authors :
Heaugwane D
Cerlati O
Belkhir K
Tarek Benkhaled B
Catrouillet S
Fabing I
Claparols C
Vedrenne M
Goudounèche D
Payré B
Lucia Bona B
Tosi A
Baldelli Bombelli F
Vicendo P
Lapinte V
Lonetti B
Mingotaud AF
Gibot L
Source :
International journal of pharmaceutics [Int J Pharm] 2024 Jun 10; Vol. 658, pp. 124186. Date of Electronic Publication: 2024 May 01.
Publication Year :
2024

Abstract

Because of the difficult challenges of nanopharmaceutics, the development of a variety of nanovectors is still highly desired. Photodynamic therapy, which uses a photosensitizer to locally produce reactive oxygen species to kill the undesired cells, is a typical example for which encapsulation has been shown to be beneficial. The present work describes the use of coumarin-functionalized polymeric nanovectors based on the self-assembly of amphiphilic poly(2-oxazoline)s. Encapsulation of pheophorbide a, a known PDT photosensitizer, is shown to lead to an increased efficiency compared to the un-encapsulated version. Interestingly, the presence of coumarin both enhances the desired photocytotoxicity and enables the crosslinking of the vectors. Various nanovectors are examined, differing by their size, shape and hydrophilicity. Their behaviour in PDT protocols on HCT-116 cells monolayers is described, the influence of their crosslinking commented. Furthermore, the formation of a protein corona is assessed.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3476
Volume :
658
Database :
MEDLINE
Journal :
International journal of pharmaceutics
Publication Type :
Academic Journal
Accession number :
38701908
Full Text :
https://doi.org/10.1016/j.ijpharm.2024.124186